Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 40

References for PMC Articles for PubMed (Select 20813948)

1.

Chemical genetics of Plasmodium falciparum.

Guiguemde WA, Shelat AA, Bouck D, Duffy S, Crowther GJ, Davis PH, Smithson DC, Connelly M, Clark J, Zhu F, Jiménez-Díaz MB, Martinez MS, Wilson EB, Tripathi AK, Gut J, Sharlow ER, Bathurst I, El Mazouni F, Fowble JW, Forquer I, McGinley PL, Castro S, Angulo-Barturen I, Ferrer S, Rosenthal PJ, Derisi JL, Sullivan DJ, Lazo JS, Roos DS, Riscoe MK, Phillips MA, Rathod PK, Van Voorhis WC, Avery VM, Guy RK.

Nature. 2010 May 20;465(7296):311-5. doi: 10.1038/nature09099.

2.

Thousands of chemical starting points for antimalarial lead identification.

Gamo FJ, Sanz LM, Vidal J, de Cozar C, Alvarez E, Lavandera JL, Vanderwall DE, Green DV, Kumar V, Hasan S, Brown JR, Peishoff CE, Cardon LR, Garcia-Bustos JF.

Nature. 2010 May 20;465(7296):305-10. doi: 10.1038/nature09107.

PMID:
20485427
3.

In vitro selection of Plasmodium falciparum drug-resistant parasite lines.

Nzila A, Mwai L.

J Antimicrob Chemother. 2010 Mar;65(3):390-8. doi: 10.1093/jac/dkp449. Epub 2009 Dec 18. Review.

4.

Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria.

Eastman RT, Fidock DA.

Nat Rev Microbiol. 2009 Dec;7(12):864-74. doi: 10.1038/nrmicro2239. Epub 2009 Nov 2. Review.

5.

New medicines to improve control and contribute to the eradication of malaria.

Wells TN, Alonso PL, Gutteridge WE.

Nat Rev Drug Discov. 2009 Nov;8(11):879-91. doi: 10.1038/nrd2972. Epub 2009 Oct 16. Review.

PMID:
19834482
6.

Artemisinin resistance in Plasmodium falciparum malaria.

Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ.

N Engl J Med. 2009 Jul 30;361(5):455-67. doi: 10.1056/NEJMoa0808859. Erratum in: N Engl J Med. 2009 Oct 22;361(17):1714.

7.

The global portfolio of new antimalarial medicines under development.

Olliaro P, Wells TN.

Clin Pharmacol Ther. 2009 Jun;85(6):584-95. doi: 10.1038/clpt.2009.51. Epub 2009 Apr 29. Review.

PMID:
19404247
8.

P-type ATPases as drug targets: tools for medicine and science.

Yatime L, Buch-Pedersen MJ, Musgaard M, Morth JP, Lund Winther AM, Pedersen BP, Olesen C, Andersen JP, Vilsen B, Schiøtt B, Palmgren MG, Møller JV, Nissen P, Fedosova N.

Biochim Biophys Acta. 2009 Apr;1787(4):207-20. Review.

PMID:
19388138
9.

Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparum.

Dharia NV, Sidhu AB, Cassera MB, Westenberger SJ, Bopp SE, Eastman RT, Plouffe D, Batalov S, Park DJ, Volkman SK, Wirth DF, Zhou Y, Fidock DA, Winzeler EA.

Genome Biol. 2009 Feb 13;10(2):R21. doi: 10.1186/gb-2009-10-2-r21.

10.

Evidence of artemisinin-resistant malaria in western Cambodia.

Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM; Artemisinin Resistance in Cambodia 1 (ARC1) Study Consortium.

N Engl J Med. 2008 Dec 11;359(24):2619-20. doi: 10.1056/NEJMc0805011. Epub 2008 Dec 8. No abstract available.

11.

Malaria research in the post-genomic era.

Winzeler EA.

Nature. 2008 Oct 9;455(7214):751-6. doi: 10.1038/nature07361. Review.

12.

Drug resistance and genetic mapping in Plasmodium falciparum.

Hayton K, Su XZ.

Curr Genet. 2008 Nov;54(5):223-39. doi: 10.1007/s00294-008-0214-x. Epub 2008 Sep 18. Review.

PMID:
18802698
13.

In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.

Plouffe D, Brinker A, McNamara C, Henson K, Kato N, Kuhen K, Nagle A, Adrián F, Matzen JT, Anderson P, Nam TG, Gray NS, Chatterjee A, Janes J, Yan SF, Trager R, Caldwell JS, Schultz PG, Zhou Y, Winzeler EA.

Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9059-64. doi: 10.1073/pnas.0802982105. Epub 2008 Jun 25.

14.

Plasmodium vivax trophozoites insensitive to chloroquine.

Sharrock WW, Suwanarusk R, Lek-Uthai U, Edstein MD, Kosaisavee V, Travers T, Jaidee A, Sriprawat K, Price RN, Nosten F, Russell B.

Malar J. 2008 May 27;7:94. doi: 10.1186/1475-2875-7-94.

15.

Qinghaosu (artemisinin): the price of success.

White NJ.

Science. 2008 Apr 18;320(5874):330-4. doi: 10.1126/science.1155165. Review.

PMID:
18420924
16.

Plasmodium falciparum Sec24 marks transitional ER that exports a model cargo via a diacidic motif.

Lee MC, Moura PA, Miller EA, Fidock DA.

Mol Microbiol. 2008 Jun;68(6):1535-46. doi: 10.1111/j.1365-2958.2008.06250.x. Epub 2008 Apr 11.

17.

Malaria: progress, perils, and prospects for eradication.

Greenwood BM, Fidock DA, Kyle DE, Kappe SH, Alonso PL, Collins FH, Duffy PE.

J Clin Invest. 2008 Apr;118(4):1266-76. doi: 10.1172/JCI33996. Review.

18.

Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar.

Guthmann JP, Pittet A, Lesage A, Imwong M, Lindegardh N, Min Lwin M, Zaw T, Annerberg A, de Radiguès X, Nosten F.

Trop Med Int Health. 2008 Jan;13(1):91-8. doi: 10.1111/j.1365-3156.2007.01978.x.

19.

Cardiotoxicity of antimalarial drugs.

White NJ.

Lancet Infect Dis. 2007 Aug;7(8):549-58. Review.

PMID:
17646028
20.

Interdomain communication in calcium pump as revealed in the crystal structures with transmembrane inhibitors.

Takahashi M, Kondou Y, Toyoshima C.

Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5800-5. Epub 2007 Mar 26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk